Welcome to LookChem.com Sign In|Join Free
  • or
6-(methylsulfanyl)-9-pentofuranosyl-9H-purin-2-amine, also known as 6-thioinosine, is a modified nucleoside with the molecular formula C10H13N5O3S. It is an analog of adenosine and contains a sulfur atom attached to the 6 position of the purine ring. This chemical compound has been studied for its potential pharmacological properties, including its inhibitory effects on purine nucleoside phosphorylase, an enzyme involved in the purine salvage pathway. Additionally, 6-thioinosine has been investigated for its antiviral and anticancer activities, making it a promising candidate for drug development and medical research.

4914-73-2

Post Buying Request

4914-73-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4914-73-2 Usage

Uses

Used in Pharmaceutical Industry:
6-(methylsulfanyl)-9-pentofuranosyl-9H-purin-2-amine is used as a pharmaceutical agent for its inhibitory effects on purine nucleoside phosphorylase. This enzyme plays a crucial role in the purine salvage pathway, and its inhibition can lead to potential therapeutic benefits in various diseases.
Used in Antiviral Applications:
6-(methylsulfanyl)-9-pentofuranosyl-9H-purin-2-amine is used as an antiviral agent due to its potential to inhibit viral replication and activity. Its antiviral properties make it a candidate for the development of new antiviral drugs to combat viral infections.
Used in Anticancer Applications:
6-(methylsulfanyl)-9-pentofuranosyl-9H-purin-2-amine is used as an anticancer agent for its potential to inhibit the growth and proliferation of cancer cells. Its anticancer activities make it a promising candidate for the development of new cancer therapies and treatments.
Used in Drug Development:
6-(methylsulfanyl)-9-pentofuranosyl-9H-purin-2-amine is used in drug development for its potential as a lead compound in the discovery of new pharmaceuticals. Its unique chemical structure and pharmacological properties make it a valuable starting point for the development of novel drugs with improved efficacy and safety profiles.
Used in Medical Research:
6-(methylsulfanyl)-9-pentofuranosyl-9H-purin-2-amine is used in medical research to study its potential applications in various diseases and conditions. Its antiviral, anticancer, and enzyme inhibitory properties make it an interesting subject for further investigation and understanding of its mechanisms of action and potential therapeutic benefits.

Check Digit Verification of cas no

The CAS Registry Mumber 4914-73-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,9,1 and 4 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 4914-73:
(6*4)+(5*9)+(4*1)+(3*4)+(2*7)+(1*3)=102
102 % 10 = 2
So 4914-73-2 is a valid CAS Registry Number.

4914-73-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(2-amino-6-methylsulfanylpurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

1.2 Other means of identification

Product number -
Other names S-methylthioguanosine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4914-73-2 SDS

4914-73-2Downstream Products

4914-73-2Relevant academic research and scientific papers

Palladium-Catalyzed Thiomethylation via a Three-Component Cross-Coupling Strategy

Wang, Ming,Qiao, Zongjun,Zhao, Jiaoyan,Jiang, Xuefeng

supporting information, p. 6193 - 6197 (2018/09/25)

In this report, the combination of masked inorganic sulfur and dimethyl carbonate was designed to achieve thiomethylated cross coupling of aryl chlorides. Remarkably, this powerful strategy realized thiomethylation of nucleosides bearing unprotected ribose, chloride-containing pharmaceuticals with late-stage coupling, and herbicides possessing multiple heteroatoms and steric hindrance. Moreover, this protocol is practically amenable to multigram-scale synthesis with a lower catalysis loading and a higher yield.

Methyl aryl thioether compound, and synthetic method and applications thereof

-

Paragraph 0149; 0150; 0151, (2017/07/21)

The invention discloses a methyl aryl thioether compound represented by formula 2, and a synthetic method and applications thereof. According to the synthetic method, in a reaction solvent, an aryl halide or an aromatic halide, dimethyl carbonate, and potassium thioacetate are taken as reaction raw materials, reaction is carried out in the presence of metal palladium catalyst under the action of a ligand and an alkali so as to obtain the methyl aryl thioether compound. The reaction conditions of the synthetic method are mild; the raw materials are cheap and easily available; reaction operation is simple; yield is relatively high. The methyl aryl thioether compound can be used for providing skeleton structures for the synthesis of a plurality of natural products and medicines, and can be widely applied in industrialized large-scale production.

Production, characterization and synthetic application of a purine nucleoside phosphorylase from Aeromonas hydrophila

Ubiali, Daniela,Serra, Carla D.,Serra, Immacolata,Morelli, Carlo F.,Terreni, Marco,Albertini, Alessandra M.,Manitto, Paolo,Speranzab, Giovanna

experimental part, p. 96 - 104 (2012/04/11)

Purine nucleoside phosphorylase (PNP) from Aeromonas hydrophila encoded by the deoD gene has been over-expressed in Escherichia coli, purified, characterized about its substrate specificity and used for the preparative synthesis of some 6-substituted purine-9-ribosides. Substrate specificity towards natural nucleosides showed that this PNP catalyzes the phosphorolysis of both 6-oxo- and 6-aminopurine (deoxy)ribonucleosides. A library of nucleoside analogues was synthesized and then submitted to enzymatic phosphorolysis as well. This assay revealed that 1-, 2-, 6- and 7-modified nucleosides are accepted as substrates, whereas 8-substituted nucleosides are not. A few transglycosylation reactions were carried out using 7-methylguanosine iodide (4) as a d-ribose donor and 6-substituted purines as acceptor. In particular, following this approach, 2- amino-6-chloropurine-9-riboside (2c), 6-methoxypurine- 9-riboside (2d) and 2-amino-6-(methylthio)purine- 9-riboside (2g) were synthesized in very high yield and purity.

Evidence for the existence of a specific gprotein-coupled receptor activated by guanosine

Volpini, Rosaria,Marucci, Gabriella,Buccioni, Michela,DalBen, Diego,Lambertucci, Catia,Lammi, Carmen,Mishra, Ram C.,Thomas, Ajiroghene,Cristalli, Gloria

experimental part, p. 1074 - 1080 (2012/01/06)

Guanosine, released extracellularly from neurons and glial cells, plays important roles in the central nervous system, including neuroprotection. The innovative DELFIA Eu-GTP binding assay was optimized for characterization of the putative guanosine receptor binding site at rat brain membranes by using a series of novel and known guanosine derivatives. These nucleosides were prepared by modifying the purine and sugar moieties of guanosine at the 6- and 5'-positions, respectively. Results of these experiments prove that guanosine, 6-thioguanosine, and their derivatives activate a Gprotein-coupled receptor that is different from the well-characterized adenosine receptors. Catching the elusive guanosine receptor: The innovative DELFIA Eu-GTP binding assay was applied to characterize the guanosine binding site by using novel and known guanosine derivatives. Some of the tested compounds, which proved to be full agonists with EC50 values in the low nanomolar range, could be useful tools for further characterization of the putative guanosine receptor.

High-throughput five minute microwave accelerated glycosylation approach to the synthesis of nucleoside libraries

Bookser, Brett C.,Raffaele, Nicholas B.

, p. 173 - 179 (2007/10/03)

The Vorbrueggen glycosylation reaction was adapted into a one-step 5 min/130 °C microwave assisted reaction. Triethanolamine in acetontrile containing 2% water was determined to be optimal for the neutralization of trimethylsilyl inflate allowing for direct MPLC purification of the reaction mixture. When coupled with a NH3/methanol deprotection reaction, a high-throughput method of nucleoside library synthesis was enabled. The method was demonstrated by examining the ribosylation of 48 nitrogen containing heteroaromatic bases that included 25 purines, four pyrazolopyrimidines, two 8-azapurines, one 2-azapurine, two imidazopyridines, two benzimidazoles, three imidazoles, three 1,2,4-triazoles, two pyrimidines, two 3-deazapyrimidines, one quinazolinedione, and one alloxazine. Of these, 32 yielded single regioisomer products, and six resulted in separable mixtures. Seven examples provided inseparable regioisomer mixtures of -two to three compounds (16 nucleosides), and three examples failed to yield isolable products. For the 45 single isomers isolated, the average two-step overall yield ± SD was 26 ± 16%, and the average purity ± SD was 95 ± 6%. A total of 58 different nucleosides were prepared of which 15 had not previously been accessed directly from glycosylation/deprotection of a readily available base.

Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase

Krynetski, Eugene Y.,Krynetskaia, Natalia F.,Yanishevski, Yuri,Evans, William E.

, p. 1141 - 1147 (2007/10/03)

Thiopurine S-methyltransferase (TPMT), a cytosolic enzyme that exhibits genetic polymorphism, catalyzes S-methylation of mercaptopurine (MP) and thioguanine (TG), yielding S-methylated nucleobases that are inactive, whereas S-methylated nucleotides of these thiopurines are cytotoxic. A yeast- based heterologous expression system was therefore used to characterize human TPMT-catalyzed methylation of MP, TG, and their principal nucleotide metabolites [thioinosine monophosphate (TIMP) and thioguanosine monophosphate (TGMP), respectively]. MP, TG, TIMP, and TGMP were all substrates for human TPMT, exhibiting similar Michaelis-Menten kinetic parameters (K(m), 10.6- 27.1 μM; V(max), 31-59 nmol/min/mg of TPMT). Consistent with these kinetic parameters, human leukemia cells (CEM) incubated for 24 hr with 10 μM MP or TG accumulated significantly higher (2.3-fold, p = 0.01) concentrations of methyl-TIMP after MP incubation than methyl-TGMP after TG incubation, due to the 2.7-fold higher concentration of TIMP after MP incubation, compared with TG nucleotides (TGN) after TG incubation. Moreover, intracellular accumulation of TGN was 2.5-fold greater after TG incubation than after MP incubation (p = 0.01). These data establish that MP, TG, and their principal nucleotide metabolites are comparable substrates for polymorphic TPMT, and they demonstrate significant differences in the accumulation of active TGN and methylated nucleotides when leukemia cells are treated with MP versus TG.

Photoinduced Alkylthiolation of Halogenated Purine Nucleosides

Nair, Vasu,Young, David A.

, p. 450 - 453 (2007/10/02)

A new highly efficient methodology for the synthesis of biologically important methylmercaptopurine nucleosides is described.The approach represents a substantial improvement over earlier reported methods for this class of compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4914-73-2